WHO ICTRP trial
Clinical study carried out to investigate the efficacy of two probiotic…
ISRCTN15032219 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN15032219 |
|---|---|
| Public title | Clinical study carried out to investigate the efficacy of two probiotic formulates on irritable bowel syndrome |
| Scientific title | Effects of multispecies probiotic supplementation on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial |
| Primary sponsor | Farcoderm S.R.L. |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Italy |
| Conditions | Irritable bowel syndrome associated constipation (IBS-C) Digestive System Irritable bowel syndrome associated constipation (IBS-C) |
| Interventions | For the study 150 adult subjects, diagnosed with irritable bowel syndrome associated to constipation (IBS-C) were enrolled and divided in three groups (F_1, F_2, F_3). Each group received a daily oral administration of different probiotic… |
| Registration date | Apr 19, 2016 |
| Target size | 150 |
| Secondary IDs | MI.02.DS.L_2013/PROBIOPLUS 4 FOOD |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: